NRP inhibitors (Helsinn/Scientific Centre of Monaco)

N/A

Report date: 2025/03/20 10:01:41
NME

Base Information

Drug NameNRP inhibitors (Helsinn/Scientific Centre of Monaco)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNeuropilin-1 inhibitorsNeuropilin 2 inhibitors
TargetsNeuropilin 2Neuropilin-1
Therapy Area/IndicationsCarcinoma, Renal Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerlandMonaco
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCentre Scientifique De Monaco
China Registration ClassN/A

Develop Information

Active CompaniesCentre Scientifique De Monaco3B Future Health Fund
Inactive CompaniesN/A
Active IndicationsCarcinoma, Renal Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A